Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

SandboxAQ Launches AQPotency, Bringing Ultrafast Virtual Screening to Drug Discovery ...

19 August 2026 · By · Wire by Fusion42

Published

19 August 2026

Topic

opportunities

◆ Sectors

Drug Discovery

◆ Source

Read at prnewswire.com →

◆ Verified

Fusion42 · 19 August 2026 · Fusion42 review

SandboxAQ has released AQPotency, a quantum-powered platform that enables ultrafast virtual screening for drug discovery without requiring a solved protein structure, accelerating early-stage pharmaceutical development.

This Wire brief sits within Fusion42's coverage of Drug Discovery.

◆ ◆ The Wire takeaway

You can now speed up drug candidate screening without needing detailed protein structures, cutting early discovery timelines. This shift opens new routes to innovate faster in pharmaceutical research using quantum computing.

◆ Coverage

1 source · 19 Aug 2026

◆ Related on Wire

◆ Topics

Drug Discoveryquantum-computingdrug-discoveryvirtual-screeningpharma-techai-ml